Результати пошуку - Mounzer Agha

  • Показ 1 - 10 результатів із 10
Уточнити результати
  1. 1
    Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients

    Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients за авторством Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar

    Опубліковано 2021
    Отримати повний текст
    Pré-impressão
    Додати у Вибране
    Збережено в:
  2. 2
    Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era

    Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era за авторством Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study

    Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 o... за авторством Suzanne Lentzsch, Amy K. O’Sullivan, Ryan Kennedy, Mohammad Abbas, Lijun Dai, Silvana Pregja, Steve Burt, Michael Boyiadzis, G. David Roodman, Markus Y. Mapara, Mounzer Agha, John Waas, Yongli Shuai, Daniel P. Normolle, Jeffrey A. Zonder

    Опубліковано 2012
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma Not Intended for Transplant: A Randomized, Phase 3 Study (CARTITUDE-5)

    Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly... за авторством Dominik Dytfeld, Binod Dhakal, Mounzer Agha, Salomon Manier, Michel Delforge, Steven Kuppens, Salma Afifi, William Deraedt, Agne Taraseviciute-Morris, Jordan M. Schecter, Jane Gilbert, Fevzi Fırat Yalniz, Erika Florendo, Lida Pacaud, Vânia Hungria, Saad Z. Usmani, María‐Victoria Mateos

    Опубліковано 2021
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma

    Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Rela... за авторством Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander M. Lesokhin, Nikhil C. Munshi, Elizabeth O’Donnell, A. Keith Stewart, Jordan M. Schecter, Jeffrey L. Goldberg, Carolyn C. Jackson, Tzu‐Min Yeh, Arnob Banerjee, Alicia J. Allred, Enrique Zudaire, William Deraedt, Deepu Madduri, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Yi Lin, Sundar Jagannath

    Опубліковано 2021
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

    Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up за авторством Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja, Mounzer Agha, Adam D. Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander M. Lesokhin, Nikhil C. Munshi, Elizabeth O’Donnell, A. Keith Stewart, Jordan M. Schecter, Jeffrey L. Goldberg, Carolyn C. Jackson, Tzu‐Min Yeh, Arnob Banerjee, Alicia J. Allred, Enrique Zudaire, William Deraedt, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Deepu Madduri, Andrzej Jakubowiak, Yi Lin, Sundar Jagannath

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

    Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cel... за авторством Matthew K. Hensley, William Bain, Jana L. Jacobs, Sham Nambulli, Urvi M. Parikh, Anthony R. Cillo, Brittany Staines, Amy Heaps, Michele D. Sobolewski, Linda J. Rennick, Bernard Macatangay, Cynthia Klamar-Blain, Georgios D. Kitsios, Barbara A. Methé, Ashwin Somasundaram, Tullia C. Bruno, Carly Cardello, Feng Shan, Creg J. Workman, Prabir Ray, Anuradha Ray, Janet Lee, Rahil Sethi, William E. Schwarzmann, Mark S. Ladinsky, Pamela J. Björkman, Dario A.A. Vignali, W. Paul Duprex, Mounzer Agha, John W. Mellors, Kevin D. McCormick, Alison Morris, Ghady Haidar

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

    CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma за авторством Deepu Madduri, Jesús G. Berdeja, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, A. Keith Stewart, Parameswaran Hari, Myo Htut, Elizabeth O’Donnell, Nikhil C. Munshi, David Avigan, Abhinav Deol, Alexander M. Lesokhin, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Yunsi Olyslager, Arnob Banerjee, Jeffrey L. Goldberg, Jordan M. Schecter, Carolyn C. Jackson, William Deraedt, Sen Hong Zhuang, Jeffrey R. Infante, Dong Geng, Xiaoling Wu, Marlene J. Carrasco, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Sundar Jagannath, Yi Lin, Thomas G. Martin

    Опубліковано 2020
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

    Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocomp... за авторством Ghady Haidar, Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum, Rachel Troyan, Scott D. Rothenberger, Deborah McMahon, Melissa Crandall, Michele D Sobolewksi, P. Nathan Enick, Jana L. Jacobs, Kevin Collins, Cynthia Klamar-Blain, Bernard Macatangay, Urvi M. Parikh, Amy Heaps, Lindsay Coughenour, Marc Schwartz, Jeffrey Dueker, Fernanda P. Silveira, Mary Keebler, Abhinav Humar, James D. Luketich, Matthew R. Morrell, Joseph M. Pilewski, John F. McDyer, Bhanu Pappu, Robert L. Ferris, Stanley M. Marks, John K. Mahon, Katie Mulvey, Sundaram Hariharan, Glenn Updike, Lorraine Brock, Robert P. Edwards, Richard H. Beigi, Paula L. Kip, Alan Wells, Tami Minnier, Derek C. Angus, John W. Mellors

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

    Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma за авторством Paul G. Richardson, Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje, Eva Medvedova, Philip L. McCarthy, Edward N. Libby, Peter M. Voorhees, Robert Z. Orlowski, Larry D. Anderson, Jeffrey A. Zonder, Carter P. Milner, Cristina Gasparetto, Mounzer Agha, Abdullah Khan, David D. Hurd, Krisstina Gowin, Rammurti T. Kamble, Sundar Jagannath, Nitya Nathwani, Melissa Alsina, Robert F. Cornell, Hamza Hashmi, Erica Campagnaro, Astrid C. Andreescu, Teresa Gentile, Michaela Liedtke, Kelly Godby, Adam D. Cohen, Thomas H. Openshaw, Marcelo C. Pasquini, Sergio Giralt, Jonathan L. Kaufman, Andrew J. Yee, Emma C. Scott, Pallawi Torka, Amy Foley, Mariateresa Fulciniti, Kyle Hebert, Mehmet Samur, Kelly Masone, Michelle E. Maglio, Andrea A. Zeytoonjian, Omar Nadeem, Robert Schlossman, Jacob P. Laubach, Claudia E. Paba‐Prada, Irene M. Ghobrial, Aurore Perrot, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Kenneth C. Anderson, Nikhil C. Munshi

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: